We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$9.69B
AUM Growth
+$805M
Cap. Flow
+$420M
Cap. Flow %
4.33%
Top 10 Hldgs %
28.55%
Holding
286
New
47
Increased
108
Reduced
76
Closed
36

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$93.3M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$64.9M
3
AMZN icon
Amazon
AMZN
+$58.3M
4
SYK icon
Stryker
SYK
+$56.3M
5
PRAH
PRA Health Sciences, Inc.
PRAH
+$49.9M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$77M
2
AMGN icon
Amgen
AMGN
+$72.2M
3
AET
Aetna Inc
AET
+$65.7M
4
CELG
Celgene Corp
CELG
+$54.3M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$52.8M

Sector Composition

Rank Sector Weight
1 Financials 21.51%
2 Healthcare 20.26%
3 Technology 19.08%
4 Communication Services 10.55%
5 Industrials 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MAIN icon
201
Main Street Capital
MAIN
$4.97B
$3.97M 0.04%
99,914
+2,500
+3% +$101K
LRCX icon
202
Lam Research
LRCX
$382B
$3.96M 0.04%
215,100
-1,544,840
-88% -$30.4M
TMO icon
203
Thermo Fisher Scientific
TMO
$211B
$3.76M 0.04%
+19,819
New +$3.8M
NMFC icon
204
New Mountain Finance
NMFC
$646M
$3.73M 0.04%
275,000
+75,000
+38% +$1.06M
VRNS icon
205
Varonis Systems
VRNS
$5.25B
$3.71M 0.04%
229,542
-178,134
-44% -$2.79M
EMR icon
206
Emerson Electric
EMR
$82.9B
$3.58M 0.04%
+51,326
New +$3.33M
ROP icon
207
Roper Technologies
ROP
$36.3B
$3.49M 0.04%
+13,492
New +$3.46M
ROK icon
208
Rockwell Automation
ROK
$51.4B
$3.41M 0.04%
+17,366
New +$3.31M
ISRG icon
209
Intuitive Surgical
ISRG
$121B
$3.33M 0.03%
+27,345
New +$3.42M
IPHI
210
DELISTED
INPHI CORPORATION
IPHI
$3.26M 0.03%
88,930
-26,000
-23% -$1.02M
ZD icon
211
Ziff Davis
ZD
$1.9B
$3.21M 0.03%
49,167
-18,400
-27% -$1.2M
ARRY
212
DELISTED
Array Biopharma Inc
ARRY
$3.2M 0.03%
250,000
– –
HMSY
213
DELISTED
HMS Holdings Corp.
HMSY
$3.13M 0.03%
185,000
+35,000
+23% +$613K
BLUE
214
DELISTED
bluebird bio
BLUE
$3.12M 0.03%
+1,351
New +$2.74M
ASND icon
215
Ascendis Pharma A/S
ASND
$16.7B
$3M 0.03%
+75,000
New +$2.73M
ALDR
216
DELISTED
Alder Biopharmaceuticals
ALDR
$2.86M 0.03%
+250,000
New +$2.79M
HDB icon
217
HDFC Bank
HDB
$119B
$2.54M 0.03%
99,804
+5,532
+6% +$132K
ANAB icon
218
AnaptysBio
ANAB
$1.6B
$2.52M 0.03%
25,000
-25,000
-50% -$1.84M
TSM icon
219
TSMC
TSM
$2.09T
$2.39M 0.02%
60,228
-20,540
-25% -$832K
CBAY
220
DELISTED
Cymabay Therapeutics
CBAY
$2.3M 0.02%
+250,000
New +$2.14M
MCHP icon
221
Microchip Technology
MCHP
$42.8B
$2.16M 0.02%
+49,138
New +$2.22M
ADI icon
222
Analog Devices
ADI
$181B
$2.11M 0.02%
+23,661
New +$2.1M
TWLO icon
223
Twilio
TWLO
$29.1B
$1.94M 0.02%
82,293
-28,273
-26% -$794K
KVHI icon
224
KVH Industries
KVHI
$177M
$1.89M 0.02%
182,497
+133,897
+276% +$1.49M
MTLS
225
Materialise
MTLS
$379M
$1.78M 0.02%
141,662
– –
7 8
9
10 11

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Polar Capital held 286 positions worth $9.69B, up 9.1% from $8.89B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Polar Capital deployed $420M of net new capital in Q4 2017, opening 47 new positions and adding to 108 existing holdings. Its largest new stake was Alnylam Pharmaceuticals: 516,232 shares worth $65.6M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Aetna Inc, an estimated $65.7M trimmed.

  • Polar Capital's largest Q4 2017 buy was Alnylam Pharmaceuticals: 516,232 shares worth $65.6M.
  • Polar Capital added most to Microsoft in Q4 2017, an estimated $93.3M increase.
  • Polar Capital's biggest Q4 2017 reduction was Aetna Inc, cutting an estimated $65.7M.
  • Polar Capital fully exited PepsiCo in Q4 2017, selling an estimated $77M.
  • Polar Capital's ten largest holdings make up 29% of its $9.69B portfolio in Q4 2017.
  • Polar Capital opened 47 new positions and closed 36 in Q4 2017.
  • Polar Capital's portfolio value rose 9.1% quarter-over-quarter to $9.69B.

Based on Polar Capital's 13F filing for Q4 2017, filed 14 Feb 2018.